N. Turner

Molecular Biology · Nature Reviews. Cancer · 2004–2022

A researcher in the Science corpus: 19 papers; trusts 2 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

Whom N. Turner trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Charles M. Perou
  2. R. Anjum
  3. D. Ornitz
  4. M. Mohammadi
  5. S. Werner
  6. D. Altomare
  7. R. Finn
  8. W. Foulkes
  9. Peter A. Jones
  10. Torsten O. Nielsen

Who trusts N. Turner overall

  1. C. Lord
  2. Alan Ashworth
  3. J. Reis-Filho
  4. Jane E. Visvader
  5. D. Ornitz
  6. N. Itoh
  7. Andrew Tutt
  8. K. J. Chavez
  9. Lisa A. Carey
  10. Fanxin Long

Papers from N. Turner's perspective

Ordered by how strongly the researchers N. Turner trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Repeated observation of breast tumor subtypes in independent gene expression data sets (Proceedings of the National Academy of Sciences of the United States of America)
  2. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma (Clinical Cancer Research)
  3. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. (Journal of Clinical Oncology)
  4. Stromal gene expression predicts clinical outcome in breast cancer (Nature Medicine)
  5. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. (Journal of the National Cancer Institute)
  6. Gene-expression profiles in hereditary breast cancer. (New England Journal of Medicine)
  7. Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer (Journal of the National Cancer Institute)
  8. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. (Genes & Development)
  9. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy (Nature)
  10. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. (Journal of the National Cancer Institute)

Their papers